CytomX News

Earnings Preview: CytomX to Report Financial Results Post-market on November 07

$CytomX(CTMX.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $CytomX(CTMX.US)$ to post revenue of USD17.10M for 2024Q3, down 35.19%

Futu NewsNov 1 13:45

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

GlobeNewswireOct 31 20:00

H.C. Wainwright Sticks to Their Hold Rating for CytomX Therapeutics (CTMX)

TipRanksSep 13 18:17 · Ratings

Express News | CytomX Therapeutics Announces First Patient Dosed With Cx-801, a Dually-Masked Interferon-Alpha 2B Probody®, in a Phase 1 Study in Patients With Solid Tumors

BreakingsSep 9 20:00

CytomX Therapeutics Announces First Patient Dosed With CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY, in a Phase 1 Study in Patients With Solid Tumors

Yahoo FinanceSep 9 20:00

CytomX Therapeutics to Present at Upcoming September Investor Conferences

GlobeNewswireSep 4 20:00

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX)

TipRanksAug 22 21:20 · Ratings

HC Wainwright & Co. Reiterates Neutral on CytomX Therapeutics

BenzingaAug 22 19:31

CytomX Therapeutics Analyst Ratings

BenzingaAug 22 19:30 · Ratings

H.C. Wainwright Maintains CytomX(CTMX.US) With Hold Rating

H.C. Wainwright analyst Mitchell Kapoor maintains $CytomX(CTMX.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 39.7% and a total average return of -10.8% over

Futu NewsAug 22 18:31 · Ratings

CytomX Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceAug 10 20:37

CytomX Therapeutics Files $250M Mixed Securities Shelf

Seeking AlphaAug 10 04:14

Express News | CytomX Therapeutics - Sales Agreement Prospectus Covering Offering of up to $58.3 Mln Common Stock That May Be Issued From Time to Time

BreakingsAug 10 04:09

Express News | CytomX Therapeutics Inc Files for Mixed Shelf of up to $250 Mln – SEC Filing

BreakingsAug 10 04:08

Earnings Call Summary | CytomX(CTMX.US) Q2 2024 Earnings Conference

Futu NewsAug 10 02:21 · Conference Call

Express News | CytomX Therapeutics Inc : BMO Cuts Target Price to $3.56 From $3.59

BreakingsAug 9 19:45

CytomX Therapeutics (CTMX) Receives a Buy From Barclays

TipRanksAug 9 15:51 · Ratings

CytomX | 10-Q: Q2 2024 Earnings Report

SECAug 9 04:50 · Announcements

Earnings Flash (CTMX) CYTOMX THERAPEUTICS Reports Q2 Revenue $25.1M, Vs. Street Est of $20M

MT NewswiresAug 9 04:48

CytomX GAAP EPS of -$0.08 Misses by $0.01, Revenue of $25.11M Beats by $5.12M

Seeking AlphaAug 9 04:42